Impact BioMedical (IBO) vs Veru (VERU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Impact BioMedical (IBO) has outperformed Veru (VERU) over the past year, losing 42.7% versus a loss of 43.4%. Veru is the larger company by market cap ($41.2 million vs $37.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IBO | VERU |
|---|---|---|
| Share price | $4.35 | $2.42 |
| Market cap | $37.17M | $41.18M |
| 1-day change | -2.90% | -1.83% |
| YTD return | -29.92% | +14.95% |
| 1-year return | -42.73% | -43.45% |
| 5-year return | — | -97.14% |
| P/E ratio (TTM) | 0.39 | — |
| EPS (TTM) | $11.11 | $-0.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.51 | $7.33 |
| 52-week low | $4.10 | $2.05 |
| Distance from 52-week high | -58.60% | -67.05% |
| Average volume | 11.61K | 242.56K |
| Shares outstanding | 8.54M | 17.05M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
IBO vs VERU FAQ
Which is bigger, Impact BioMedical or Veru?
Veru (VERU) is larger, with a market capitalization of $41.18M compared with $37.17M for Impact BioMedical (IBO).
Which stock has performed better over the past year, IBO or VERU?
IBO returned -42.73% over the past 12 months, compared with -43.45% for VERU (price return, excluding dividends). Past performance does not predict future results.
Are Impact BioMedical and Veru in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.